无缝线或带支架瓣膜置换术后起搏器植入:一项对照随机试验结果
PERSIST-AVR 前瞻性随机开放标签试验纳入行主动脉瓣置换患者,随机接受无缝线主动脉瓣(Su-AVR,n=450)或带支架缝合生物瓣(SAVR,n=446)。Su-AVR 组早期永久起搏器植入(PPI)率为 10.4%,SAVR 组为 3.1%;Su-AVR 组 PPI 与 XL 型号瓣膜(P=0.0119)及术前传导障碍(P=0.0079)相关,SAVR 组未发现预测因素。
要点
- Su-AVR 组早期 PPI 率 10.4%,SAVR 组 3.1%。
- Su-AVR 组 PPI 与瓣膜 XL 型号(P=0.0119)及术前传导障碍(P=0.0079)相关。
- SAVR 组未发现 PPI 预测因素。
核心结论
- Su-AVR 较 SAVR 与更高的 PPI 率相关,但 PPI 率增加似乎呈瓣膜尺寸依赖性,仅 XL 型号显著更高。
- 术前传导障碍合并 XL 型号可导致 Su-AVR 早期 PPI 概率更高。
研究设计与样本
- PERSIST-AVR 为前瞻性、随机、开放标签试验,患者随机接受无缝线主动脉瓣置换(Su-AVR)或带支架缝合生物瓣置换(SAVR)。
- Su-AVR 组 n=450,SAVR 组 n=446,两组术前危险因素均衡。
- 采用多变量分析识别与 PPI 相关的独立危险因素,并以逻辑回归分析估计不同瓣膜尺寸相关 PPI 风险。
- 临床试验注册号 NCT02673697。
主要发现
- 早期 PPI 率 Su-AVR 组为 10.4%,SAVR 组为 3.1%。
- Su-AVR 组 PPI 与 XL 型号瓣膜(P=0.0119)及术前传导障碍(P=0.0079)相关。
- SAVR 组未发现 PPI 预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Sutureless aortic valves demonstrated non-inferiority to standard stented valves for major cardiovascular and cerebral events at 1 year after aortic valve replacement. We aim to assess the factors correlating with permanent pacemaker implantation (PPI) in both cohorts. METHODS: PERSIST-AVR is a prospective, randomized, open-label trial. Patients undergoing aortic valve replacement were randomized to receive a sutureless aortic valve replacement (Su-AVR) or stented sutured bioprosthesis (SAVR). Multivariable analysis was performed to identify possible independent risk factors associated with PPI. A logistic regression analysis was performed to estimate the risk of PPI associated to different valve size. RESULTS: The 2 groups (Su-AVR; n = 450, SAVR n = 446) were well balanced in terms of preoperative risk factors. Early PPI rates were 10.4% in the Su-AVR group and 3.1% in the SAVR. PPI prevalence correlated with valve size XL (P = 0.0119) and preoperative conduction disturbances (P = 0.0079) in the Su-AVR group. No predictors were found in the SAVR cohort. Logistic regression analysis showed a significantly higher risk for PPI with size XL compared to each individual sutureless valve sizes [odds ratio (OR) 0.272 vs size S (95%confidence interval 0.07-0.95), 0.334 vs size M (95% CI 0,16-0; 68), 0.408 vs size L (95% CI 0,21-0.81)] but equivalent risk of PPI rates for all other combination of valve sizes. CONCLUSIONS: Su-AVR is associated with higher PPI rate as compared to SAVR. However, the increased PPI rate appears to be size-dependent with significant higher rate only for size XL. The combination of preoperative conduction disorder and a size XL can lead to a higher probability of early PPI in Su-AVR. CLINICAL TRIAL REGISTRATION NUMBER: NCT02673697.
引用
- Lorusso R, Ravaux JM, Pollari F, et al. Pacemaker implantation after sutureless or stented valve: results from a controlled randomized trial. Eur J Cardiothorac Surg. 2022. PMID: 35290444. doi:10.1093/ejcts/ezac164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。